Systematic Benchmarking of CRISPR-Cas9 Off-Target Prediction Tools Reveals Limitations and Implications for Preclinical Assessment. - Kaufmann MM; Hackenberg M; Jobson Pargeter W; Backofen R; Binder H; Cathomen T (Human gene therapy, 2026)